戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 tion in a patient presenting with aggressive pyoderma gangrenosum.
2  samples confirmed the clinical suspicion of pyoderma gangrenosum.
3 stations included pathergy, cystic acne, and pyoderma gangrenosum.
4 ations are discussed regarding psoriasis and pyoderma gangrenosum.
5 d skin ulcers with a clinical resemblance to pyoderma gangrenosum.
6 abscesses and pretibial lesions diagnosed as pyoderma gangrenosum.
7 ic vasculitides such as Sweet's syndrome and pyoderma gangrenosum.
8 ter initial item deletion (Erythema nodosum, Pyoderma gangrenosum), a 7-item scale was estimated.
9 port mapping of a disease locus for familial pyoderma gangrenosum-acne-arthritis to the long arm of c
10  abdominal wall lesions were suspected to be pyoderma gangrenosum although biopsies were equivocal.
11 e in which cutaneous manifestations, such as pyoderma gangrenosum and acne fulminans, predominated.
12 arthritis and less frequently accompanied by pyoderma gangrenosum and acne.
13 mic inflammatory disease; pyogenic arthritis pyoderma gangrenosum and acne; Muckle-Wells syndrome; fa
14 from patients with Sweet's syndrome (SW) and pyoderma gangrenosum and found numerous novel splice var
15 reduced in tissue samples from patients with pyoderma gangrenosum and healthy controls.
16  functions of PSTPIP1 in the pathogenesis of pyoderma gangrenosum and suggest that the cytoskeleton i
17  report a case of CB, initially diagnosed as pyoderma gangrenosum and treated with steroids, leading
18                  Pyogenic sterile arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome (OMIM 604
19  dominant disease called pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome.
20 to cause the syndrome of pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA), a dominantly inhe
21                          Pyogenic Arthritis, Pyoderma Gangrenosum, and Acne Syndrome (PAPA syndrome)
22 generation (MRST); and a pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA).
23 ver syndrome and pyogenic sterile arthritis, pyoderma gangrenosum, and acne syndrome.
24   PAPA syndrome (pyogenic sterile arthritis, pyoderma gangrenosum, and acne, OMIM #604416) and famili
25 e PAPA syndrome: pyogenic sterile arthritis, pyoderma gangrenosum, and acne.
26  patients with Sweet syndrome, patients with pyoderma gangrenosum, and healthy controls.
27 lymphocutaneous spread, clinically mimicking pyoderma gangrenosum, and subsequently progressed to dis
28  of the 157 consecutive patients treated for pyoderma gangrenosum at our institution (10 percent).
29 illation-associated disease and suggest that pyoderma gangrenosum can be classified as a dynamical di
30 gnosis of exclusion, and the misdiagnosis of pyoderma gangrenosum can result in substantial complicat
31                                              Pyoderma gangrenosum, cystic acne, and aseptic arthritis
32 Among other entities, CB may be mistaken for pyoderma gangrenosum due to overlap of findings on histo
33 95 patients studied, 64 had been treated for pyoderma gangrenosum for a median of 10 months (range, 3
34 57 consecutive patients treated for presumed pyoderma gangrenosum from 1984 through 1992.
35 rma gangrenosum (PPG), an unusual variant of pyoderma gangrenosum, has been reported almost exclusive
36             Here we report the first case of pyoderma gangrenosum in a patient with refractory celiac
37 required in all patients suspected of having pyoderma gangrenosum in order to rule out alternative di
38                                              Pyoderma gangrenosum is a diagnosis of exclusion, and th
39                                              Pyoderma gangrenosum is an inflammatory neutrophilic der
40                                              Pyoderma gangrenosum is associated with a concomitant sy
41                          The misdiagnosis of pyoderma gangrenosum is not uncommon and exposes patient
42 Of the ulcers in the 64 patients treated for pyoderma gangrenosum, it was clear that those in 23 pati
43 ssibility that refractory celiac disease and pyoderma gangrenosum may be immunologically different.
44 s detected in all other patients with either pyoderma gangrenosum or SW, it was always associated wit
45                                            A pyoderma gangrenosum patient exhibiting aberrant leukocy
46 ines for determining patient eligibility for pyoderma gangrenosum (PG) clinical trials.
47                                              Pyoderma Gangrenosum (PG) is a cutaneous condition, its
48                                              Pyoderma gangrenosum (PG) is a neutrophilic dermatosis o
49                                              Pyoderma gangrenosum (PG) is a rare neutrophilic dermato
50                                              Pyoderma gangrenosum (PG) is an important disease with s
51                                              Pyoderma gangrenosum (PG) is an inflammatory condition c
52             Unlike erythema nodosum (EN) and pyoderma gangrenosum (PG), LCV requires biopsy for diagn
53                                   Peristomal pyoderma gangrenosum (PPG), an unusual variant of pyoder
54 ed to other neutrophilic dermatoses, such as pyoderma gangrenosum, remain poorly understood.
55 nt) did not respond to treatment directed at pyoderma gangrenosum, those in 8 (12 percent) were exace
56                           Good resolution of pyoderma gangrenosum was achieved in 3 patients with tum
57 e charts of 240 patients with a diagnosis of pyoderma gangrenosum who were evaluated at our instituti
58 nt, rarely occurring, extra-hepatic onset of pyoderma gangrenosum, with the AIH in remission, strengt